Mathew Thomas, MD, joined the Division of Hospital Medicine as an Instructor in Medicine in July 2025. He was born in Buffalo, NY and spent most of his upbringing in Eau Claire, WI. He graduated from Boston College, MA, with a major in Mathematics and a minor in Chemistry. Thereafter, he went to medical school at Kasturba Medical College, India. He developed a particular interest in hematology/oncology and was involved in the Hemophilia Society of Manipal, educating and treating patients with recombinant clotting factor infusions for patients with hemophilia. During his residency in Internal Medicine at Riverside Medical Center in Kankakee, IL, he co-authored a quality improvement project detailing the unnecessary use of antibiotics in the treatment of asymptomatic bacteriuria. His clinical interests include preventative medicine, hematology/oncology, inpatient care, and delivering high quality patient care in underserved areas.
Education
- BS, Mathematics: Boston College, Chestnut Hill, MA (2014)
- MBBS: Kasturba Medical College, Manipal, India (2021)
- Residency, Internal Medicine: Riverside Medical Center, Kankakee, IL (2025)
Clinical Interests
Preventative medicine, hematology/oncology, inpatient care, helping underserved areas
Publications
Kata, V, Patel, D, Thomas, M, Joshi, D. S3395 Russell Body Esophagitis: Food Bolus Leads to Rare Diagnosis. The American Journal of Gastroenterology 119(10S):p S2263, October 2024. | DOI: 10.14309/01.ajg.0001042948.62989.cf
Cornell RF, Hari P, Zhang M, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR. Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2013; 19(9): 1368-1373.
Cornell RF, Thompson J, Maramattom LV, Singh V, Saad AA, Palmer J, Thomas M, Hari P. Patterns of Myeloma (MM) Progression After Autologous Transplant (AHCT)-Biochemical Progression Vs. Clinical Relapse. American Society of Hematology: blood. 2011; 118(21): 5097.
Maramattom LV, Singh V, Cornell RF, Randhawa JK, Thomas M, Saad AA, Palmer J, Hari P. Bortezomib Based Therapy for Newly Diagnosed Patients with Advanced Multisystem Light Chain Amyloidosis (AL). American Society of Hematology: blood. 2011; 118(21): 1880. PMID: 23806770.